Loss Per Share Applicable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to ChromaDex Corporation	$ (959)	$ (985)	$ (5,052)	$ (15,122)
Basic loss per common share (in dollars per share)	$ (0.01)	$ (0.01)	$ (0.07)	$ (0.22)
Diluted loss per common share (in dollars per share)	$ (0.01)	$ (0.01)	$ (0.07)	$ (0.22)
Basic weighted average common shares outstanding (in shares)	75,050	68,345	74,938	68,331
Diluted weighted average common shares outstanding (in shares)	75,050	68,345	74,938	68,331
Potentially dilutive securities:
Restricted stock units (in shares)	677	748	677	748
Nonvested shares of restricted stock (in shares)	167	183	177	183
Stock options
Potentially dilutive securities:
Stock options (in shares)	11,917	10,064	11,917	10,064